New Market Report: The Top 10 Eastern European Pharmaceutical Companies

Fast Market Research recommends "The Top 10 Eastern European Pharmaceutical Companies: Growth strategies, performance and SWOT analyses" from Business Insights, now available
 
March 30, 2010 - PRLog -- The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight in to the current state of Eastern European pharmaceutical industry as well as the evolving trends. It also provides the competitive landscape of the industry based on financial and operational (revenue growth over the last five years, exposure to major markets and presence in major therapeutic areas) parameters in the Eastern European region. The report also includes profiles of the top ten companies in the industry and also involves a brief summary of top 11 to 20 players. The top 10 companies in the Eastern European pharmaceutical industry were assessed on following parameters: each company's market share in the Eastern European pharmaceutical market; each company's marketed products, geographic and therapeutic focus; each company's growth strategies and major acquisitions and divestments in this market; key mergers and acquisitions formed by these companies; business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/54095_the_top_10_eastern_europ...

Partial Table of Contents:

The Top 10 Eastern European Pharmaceutical Companies
Executive summary 14
Industry overview 14
Novartis 15
Sanofi-Aventis 15
GlaxoSmithKline (GSK) 16
Servier 16
Roche 17
Pfizer 17
Bayer 18
Teva 18
Zentiva 19
Krka 19
Chapter 1 Introduction 22
What is this report about? 22
Methodology 22
Chapter 2 Industry overview 24
Summary 24
Introduction 25
Market dynamics 25
Eastern European market: size and growth 25
Parallel trade in Eastern Europe 27
Key market drivers and resistors 28
Competitive landscape 29
Competitive position of the top 10 companies 29
Comparative analysis of the top 10 companies 31
Trends 33
Consolidation underway 33
Increasing use of generics 33
Rise of value added generics and biosimilars 34
Cancer market represents strong commercial opportunity 35
Increasing presence of biotechnology 35
Chapter 3 Novartis 38
Summary 38
Company overview 39
Geographic focus 39
Marketed products 40
Therapeutic focus 40
Research and development 41
Growth strategies 42
Focus on biosimilars 42
Strengthening its oncology portfolio 42
Strengthening presence in Romania 43
Growing business by forging alliances and partnerships 43
Acquisitions and divestments 44
SWOT analysis 45
Chapter 4 Sanofi-Aventis 48
Summary 48
Company overview 49
Geographic focus 49
Marketed products 51
Therapeutic focus 52
Research and development 52
Growth strategies 53
Focusing on external collaborations for business development 53
Acquisitions and divestments 54
SWOT analysis 55
Chapter 5 GSK 58
Summary 58
Company overview 59
Geographic focus 59
Marketed products 61
Therapeutic focus 62
Research and development 62
Growth strategies 63
Investing in product capabilities and R&D 63
Partnerships fostering growth 64
Expanding product portfolio through new drug launches 64
Acquisitions and divestments 65
SWOT analysis 66
Chapter 6 Servier 68
Summary 68
Company overview 69
Geographic focus 69
Marketed products 71
Therapeutic focus 72
Research and development 72
Growth strategies 73
Expanding production capacity and establishing innovative drug development centers 73
Partnerships and alliances to fuel growth 73
Acquisitions and divestments 74
SWOT analysis 75
Chapter 7 Roche 78
Summary 78
Company overview 79
Geographic focus 79
Marketed products 81
Therapeutic focus 82
Research and development 82
Growth strategies 83
Sustaining sales growth for major oncology franchises through lineextensions 83
Diversifying into new therapeutic areas beyond oncology 84
Acquisitions and divestments 84
SWOT analysis 85
Chapter 8 Pfizer 88
Summary 88
Company overview 89
Geographic focus 89
Marketed products 91
Therapeutic focus 92
Research and development 92
Growth strategies 94
Expanding in the under-penetrated Russian market 94
Acquisitions and divestments 94
SWOT analysis 95
Chapter 9 Bayer 98
Summary 98
Company overview 99
Geographic focus 99
Marketed products 101
Therapeutic focus 102
Research and development 102
Growth strategies 103
Realigning focus in healthcare to improve long-term profitability 103
New product development to drive margins in Eastern Europe 104
Acquisitions and divestments 105
SWOT analysis 106
Chapter 10 Teva 108
Summary 108
Company overview 109
Geographic focus 109
Marketed products 110
Therapeutic focus 111
Research and development 111
Growth strategies 112
Leveraging the biosimilar opportunity in Europe 112

Full ToC is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=5409...

About Business Insights

Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and their aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors.  By working in association with so many experts they are able to provide clients with more incisive market analysis specific to the client's industry sector. No other market analysis company provides such focused and trusted market analysis, across such a wide range of industry sectors.  View more research from Business Insights at http://www.fastmr.com/catalog/publishers.aspx?pubid=1003

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Therapeutic, Pipeline, Divestments, Pharmaceutical, Roche, Gsk, Teva, Bayer, Novartis, Healthcare
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share